Wavelength Pharma Names Former Sun Exec as New CEO Post author:Sam Post published:November 28, 2017 Post category:BioPharma Iftach Seri previously served as Sun Pharmaceutical’s head of API. Source: BioSpace You Might Also Like How GlaxoSmithKline Lost Nearly $10B in October November 9, 2017 Medivir's Nomination Committee Proposes New Board Of Directors Ahead Of 2017 AGM February 23, 2017 <b>RPRD Diagnostics</b> Announces Strategic Collaboration With <b>Children's Minnesota</b> To Advance Clinical Pharmacogenomics February 12, 2017
<b>RPRD Diagnostics</b> Announces Strategic Collaboration With <b>Children's Minnesota</b> To Advance Clinical Pharmacogenomics February 12, 2017
